Metabolic complications with the use of mTOR inhibitors for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolic complications with the use of mTOR inhibitors for cancer therapy

Published:2014-02 Issue:1 Volume:40 Page:190-196
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Sivendran Shanthi,Agarwal Neeraj,Gartrell Benjamin,Ying Jian,Boucher Kenneth M.,Choueiri Toni K.,Sonpavde Guru,Oh William K.,Galsky Matthew D.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference32 articles.

1. mTOR and cancer: insights into a complex relationship;Sabatini;Nat Rev Cancer,2006

2. mTOR: from growth signal integration to cancer, diabetes and ageing;Zoncu;Nat Rev Mol Cell Biol,2011

3. A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C);Okuno;Cancer,2011

4. Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas;Chawla;J Clin Oncol,2012

5. A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas;Duran;Br J Cancer,2006

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug‐Induced Diabetes;Textbook of Diabetes;2024-01-12

2. Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management;Cardio-Oncology;2023-12-12

3. Screening and management of metabolic complications of mTOR inhibitors in real-life settings;Annales d'Endocrinologie;2023-12

4. Evaluating the life-extending potential and safety profile of rapamycin: a Mendelian Randomization study of the mTOR pathway;2023-10-02

5. Therapeutic potential of natural compounds from herbs and nutraceuticals in spinal cord injury: Regulation of the mTOR signaling pathway;Biomedicine & Pharmacotherapy;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3